Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care

NCT06554223 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06554223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06554223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 14, 2025
Completion date
March 31, 2029
Enrollment
310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus